| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT)
ARCT Technical Analysis
5
| As on 8th May 2025 ARCT STOCK Price closed @ 11.38 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 28.22 & Strong Sell for SHORT-TERM with Stoploss of 29.60 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ARCTSTOCK Price
| Open | 10.97 | Change | Price | % |
| High | 11.59 | 1 Day | 0.43 | 3.93 |
| Low | 10.70 | 1 Week | -1.44 | -11.23 |
| Close | 11.38 | 1 Month | -0.57 | -4.77 |
| Volume | 373792 | 1 Year | -13.61 | -54.46 |
| 52 Week High 44.39 | 52 Week Low 8.91 | ||||
NASDAQ USA Most Active Stocks
| AMRS | 0.14 | 100.00% |
| DGLY | 0.06 | 20.00% |
| GNLN | 0.01 | 0.00% |
| NVDA | 117.37 | 0.26% |
| LMDX | 0.02 | 0.00% |
| PLUG | 0.85 | 8.97% |
| AKTS | 0.04 | 0.00% |
| TSLA | 284.82 | 3.11% |
| ZKIN | 2.52 | 123.01% |
| VEEE | 7.45 | 192.16% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ARCT Daily Charts |
ARCT Intraday Charts |
Whats New @ Bazaartrend |
ARCT Free Analysis |
|
|
ARCT Important Levels Intraday
| RESISTANCE | 13.10 |
| RESISTANCE | 12.55 |
| RESISTANCE | 12.21 |
| RESISTANCE | 11.87 |
| SUPPORT | 10.89 |
| SUPPORT | 10.55 |
| SUPPORT | 10.21 |
| SUPPORT | 9.66 |
ARCT Forecast May 2025
| 4th UP Forecast | 34.27 |
| 3rd UP Forecast | 26.93 |
| 2nd UP Forecast | 22.39 |
| 1st UP Forecast | 17.85 |
| 1st DOWN Forecast | 4.91 |
| 2nd DOWN Forecast | 0.37 |
| 3rd DOWN Forecast | -4.17 |
| 4th DOWN Forecast | -11.51 |
ARCT Weekly Forecast
| 4th UP Forecast | 18.05 |
| 3rd UP Forecast | 15.91 |
| 2nd UP Forecast | 14.59 |
| 1st UP Forecast | 13.27 |
| 1st DOWN Forecast | 9.49 |
| 2nd DOWN Forecast | 8.17 |
| 3rd DOWN Forecast | 6.85 |
| 4th DOWN Forecast | 4.71 |
ARCT Forecast2025
| 4th UP Forecast | 82.6 |
| 3rd UP Forecast | 59.76 |
| 2nd UP Forecast | 45.64 |
| 1st UP Forecast | 31.52 |
| 1st DOWN Forecast | -8.76 |
| 2nd DOWN Forecast | -22.88 |
| 3rd DOWN Forecast | -37 |
| 4th DOWN Forecast | -59.84 |
Arcturus Therapeutics Holdings Inc ( NASDAQ USA Symbol : ARCT )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ARCT Business Profile
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the treatment of liver and respiratory care diseases. Its preclinical drug discovery and development programs include LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lung disease caused by mutations in cystic fibrosis transmembrane conductance regulator (CFTR) gene. The company owns LUNAR and nucleic acid technologies that are covered by a patent portfolio of 209 patents and patent applications, issued in the United States and other countries. It has collaboration partnerships with Ultragenyx Pharmaceutical, Inc. to develop mRNA therapeutic candidates for certain rare disease targets; Millennium Pharmaceuticals, Inc. (Takeda) to develop a nucleic acid-based therapeutic candidate for the treatment of nonalcoholic steatohepatitis; Janssen Pharmaceuticals, Inc. to develop nucleic acid-based therapeutic candidates for the treatment of hepatitis B virus infection; CureVac AG to develop mRNA therapeutic and vaccine candidates; Singapore Economic Development Board and Duke-NUS Medical School to develop LUNAR-COV19 vaccine. Arcturus Therapeutics Holdings Inc. was founded in 2013 and is headquartered in San Diego, California. Address: 10628 Science Center Drive, San Diego, CA, United States, 92121
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service